Kevin Kargman Dr
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), work through multiple mechanisms that influence gastric function
Our services are not intended to diagnose, treat, or manage medical conditions outside the scope of our programs
[8] [9] GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in response to elevated blood glucose Suppressing glucagon release , which reduces glucose production by the liver Slowing gastric emptying , helping you feel fuller for longer Acting on appetite centres in the brain to reduce hunger and food intake In the UK, commonly prescribed GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Lyxumia) and exenatide (Byetta, Bydureon)